BE1003256A5 - Derives de la butynylamine. - Google Patents

Derives de la butynylamine. Download PDF

Info

Publication number
BE1003256A5
BE1003256A5 BE8900977A BE8900977A BE1003256A5 BE 1003256 A5 BE1003256 A5 BE 1003256A5 BE 8900977 A BE8900977 A BE 8900977A BE 8900977 A BE8900977 A BE 8900977A BE 1003256 A5 BE1003256 A5 BE 1003256A5
Authority
BE
Belgium
Prior art keywords
alkyl group
hydrogen atom
group
butynylamine
different
Prior art date
Application number
BE8900977A
Other languages
English (en)
Inventor
Kimura Kiyoshi
Kise Masahiro
Morita Iwao
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of BE1003256A5 publication Critical patent/BE1003256A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/20—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/24—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

Dérivés de la butynylamine représentés par la formule générale (I) suivante et leurs sels pharmacologiquement acceptables, dans laquelle R1 et R2 sont des groupes cycloalkyle, phényle ou 2-thiényle identiques ou différents; R3 et R4 sont un atome d'hydrogène ou un groupe alkyle identiques ou différents ou forment ensemble un groupe cycloalkyle conjointement avec l'atome de carbone adjecent;R5 et R6 sont un atome d'hydrogène ou un groupe alkyle identiques ou différents, ou forment ensemble un groupe amino cyclique conjointement avec l'atome d'azote adjacent, et A désigne O ou NR (où R est un atome d'hydrogène ou un groupe alkyle), à l'exclusion du cas où R3 et R4 sont tous deux des atomes d'hydrogène, A est O et, au moins l'un ou l'outre des symboles R1 et R2 est un groupe phényle.
BE8900977A 1988-09-14 1989-09-14 Derives de la butynylamine. BE1003256A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23127288 1988-09-14

Publications (1)

Publication Number Publication Date
BE1003256A5 true BE1003256A5 (fr) 1992-02-11

Family

ID=16921002

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900977A BE1003256A5 (fr) 1988-09-14 1989-09-14 Derives de la butynylamine.

Country Status (13)

Country Link
US (1) US5036098B1 (fr)
EP (1) EP0359311B1 (fr)
KR (1) KR0154325B1 (fr)
CN (1) CN1038410C (fr)
BE (1) BE1003256A5 (fr)
CA (1) CA1317943C (fr)
CH (1) CH680440A5 (fr)
DE (1) DE68927657T2 (fr)
ES (1) ES2016060A6 (fr)
FR (1) FR2639044B1 (fr)
GB (2) GB8919320D0 (fr)
HU (2) HUT58045A (fr)
IL (1) IL91377A (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof
US5192779A (en) * 1989-02-14 1993-03-09 Fujisawa Pharmaceutical Co., Ltd. Substituted-acetamide compound and a process for the preparation thereof
CA2259316A1 (fr) * 1996-07-01 1998-01-08 Bridge Pharma, Inc. Agent spasmolytique de la musculature lisse, compositions et procedes d'utilisation concernant cet agent
US6541479B1 (en) * 1997-12-02 2003-04-01 Massachusetts College Of Pharmacy Calcium channel blockers
US6013830A (en) * 1998-03-30 2000-01-11 Sepracor Inc. Asymmetric grignard synthesis with cyclic 1,2 aminoalcohols
US6140529A (en) * 1998-10-22 2000-10-31 Sepracor Inc. Synthesis of optically active cyclohexylphenylglycolate esters
JP3981357B2 (ja) * 2001-10-26 2007-09-26 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 第４級アンモニウム化合物および抗ムスカリン剤としてのそれらの使用
JP2005511582A (ja) * 2001-11-05 2005-04-28 ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー 抗ムスカリン・エアゾール
TW200412945A (en) * 2002-10-25 2004-08-01 Upjohn Co Quaternary ammonium compounds
AU2003269380A1 (en) * 2002-10-29 2004-05-25 Pharmacia & Upjohn Company Llc Quinuclidinium derivatives as antimuscarinic agents
JP2006506392A (ja) * 2002-10-29 2006-02-23 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ムスカリン受容体アンタゴニストとしての第四級アンモニウム化合物
US8025587B2 (en) * 2008-05-16 2011-09-27 Taylor Made Golf Company, Inc. Golf club
BRPI0409370A (pt) * 2003-04-15 2006-04-25 Pharmacia & Upjohn Co Llc compostos de amÈnio quaternário e seus usos como agentes antimuscarìnicos
WO2004091597A2 (fr) * 2003-04-15 2004-10-28 Pharmacia & Upjohn Company Llc Procede pour traiter le syndrome du colon irritable
AU2011245499B2 (en) 2010-04-30 2014-09-25 Merck Sharp & Dohme Corp. Novel beta 3 adrenergic receptor agonists
CN116493049B (zh) * 2023-04-13 2024-10-29 石河子大学 一种用于合成乙烯基乙炔的催化剂及其制备方法、应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB940540A (en) * 1960-07-26 1963-10-30 Mead Johnson & Co Aminoacetylenes and process for preparing the same
EP0383256A2 (fr) * 1989-02-14 1990-08-22 Fujisawa Pharmaceutical Co., Ltd. Composé acétamide substitué et un procédé pour sa préparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL248231A (fr) * 1959-02-18
JPH0755904B2 (ja) * 1986-05-14 1995-06-14 小玉株式会社 膀胱疾患治療剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB940540A (en) * 1960-07-26 1963-10-30 Mead Johnson & Co Aminoacetylenes and process for preparing the same
EP0383256A2 (fr) * 1989-02-14 1990-08-22 Fujisawa Pharmaceutical Co., Ltd. Composé acétamide substitué et un procédé pour sa préparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ACTA PHARM. SUECICA, vol. 6, 1969, pages 349-358, Stockholm, SE; R. DAHLBOM et al.: "Acetylene compounds of potential pharmacological value" *

Also Published As

Publication number Publication date
KR900004728A (ko) 1990-04-12
FR2639044A1 (fr) 1990-05-18
IL91377A0 (en) 1990-04-29
HU211134A9 (en) 1995-10-30
DE68927657D1 (de) 1997-02-27
IL91377A (en) 1996-09-12
FR2639044B1 (fr) 1993-08-06
EP0359311B1 (fr) 1997-01-15
ES2016060A6 (es) 1990-10-01
GB2222828B (en) 1992-04-29
DE68927657T2 (de) 1997-07-03
EP0359311A2 (fr) 1990-03-21
CH680440A5 (fr) 1992-08-31
CA1317943C (fr) 1993-05-18
CN1041582A (zh) 1990-04-25
KR0154325B1 (ko) 1998-12-01
GB8920766D0 (en) 1989-10-25
CN1038410C (zh) 1998-05-20
US5036098A (en) 1991-07-30
GB8919320D0 (en) 1989-10-11
GB2222828A (en) 1990-03-21
US5036098B1 (en) 1993-11-02
HUT58045A (en) 1992-01-28
EP0359311A3 (fr) 1991-07-03

Similar Documents

Publication Publication Date Title
BE1003256A5 (fr) Derives de la butynylamine.
BE904945A (fr) Nouveaux derives du thiazole, leur preparation et leur utilisation en therapeutique.
ATE115952T1 (de) Pyrimidindion-derivate, verfahren zu deren herstellung und diese enthaltende antiarrythmische mittel.
DK584886D0 (da) Vanduoplaeselige, mono- og disubstituerede derivater af rapamycin og farmaceutisk acceptable salte deraf
DE69415445D1 (de) Zytotoxische Stilben-Derivate und diese enthaltende pharmazeutische Zusammensetzungen
DK202388A (da) Azabicycliske forbindelser og fremgangsmaade til fremstilling deraf
DK504889A (da) N-heterocykliske forbindelser
DK0445731T3 (da) Azabicyclo- og azacyclooxim- og -amin-choliner-giske midler og farmaceutisk acceptable salte deraf
BE1002868A4 (fr) Derives d'acylphenols.
BE1003248A5 (fr) Derives du pyroglutamide.
NO941451D0 (no) Oksazolinderivat
MY129935A (en) Dihydropyridine derivatives useful in antitumor therapy
AU2124992A (en) Pharmaceutically useful indole derivatives
TW333532B (en) Benzopyrans
FR2438048A1 (fr) Nouveaux derives de 1,3-oxazino (5,6-c) rifamycine doues d'une activite antibiotique
ATE176906T1 (de) Benzolactam-derivate
ATE55057T1 (de) Zentralwirkende muskelrelaxante.
YU72992A (sh) Derivati cikloheksana i tetrahidropirana
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
JPS6419096A (en) Tripeptide derivative having polycyclic nitrogen-containing structure
FR2637500A1 (fr) Medicaments a base de nouveaux derives de la carbonyl-2 n, n'-di-(trimethoxybenzoyle) piperazine
DE69420514D1 (de) Cyclopropan-Derivate und diese enthaltende antivirale Mittel
BE1002655A3 (fr) Derives phosphoriques des mitomycines.
DE69526332D1 (de) Indol-derivate
FR2637499A1 (fr) Medicaments a base de nouveaux derives de la methoxycarbonyl-2 n, n'-di-(trimethoxybenzoyle) piperazine

Legal Events

Date Code Title Description
RE Patent lapsed

Effective date: 20070930